Details of the Drug
General Information of Drug (ID: DMY6VPA)
| Drug Name |
Mitumomab
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
LuVax; MelVax; BEC-2; EMD-60205; IMC-BEC2; Antimelanoma antibody, ImClone/Merck KGaA; Antimetastatic agents, ImClone/Merck KGaA; Melanoma vaccine, ImClone/Merck KGaA; GD3 ganglioside (vaccine 1), Memorial Sloan-Kettering
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Monoclonal antibody
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
